RecruitingNot applicableMale onlyEN originalProstate cancer

Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

This clinical trial identifies factors associated with completing genetic testing, aids in the development of a decision support tool, and tests how well the decision support tool works to enhance germline genetic testing in patients with prostate cancer. Germline genetic testing is a guideline-recommended standard of care for many patients with prostate cancer. Completing genetic testing can enable the use of targeted therapies, offers access to novel clinical trials, provides valuable information, and can help identify at risk family members. The decision support tool may educate patients and assist in the decision to engage with germline genetic testing.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • •Pacjenci zdiagnozowani z rakiem prostaty leczeni w szpitalu LBJ.
  • •Otrzymali zalecenie wykonania badań genetycznych od swojego lekarza.
  • •Mogą wyrazić świadomą zgodę na udział w badaniu.
  • •Mogą porozumiewać się po angielsku lub hiszpańsku.

✗ Disqualifies

  • •Pacjenci z rakiem prostaty leczeni w szpitalu LBJ, którzy nie mogą wziąć udziału z powodu poważnych problemów psychicznych lub poznawczych.

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
September 25, 2026
Sex
Male only

Therapies / drugs in trial

Locations (1)

M D Anderson Cancer Center

Houston, United States

Trial contact

Debanjan Pain

PRINCIPAL_INVESTIGATOR

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/26/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.